EGEmma Eileen Graham

Emma Eileen Graham

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Emma Eileen Graham has a total of 20 co-authors. Here are the top co-authors by number of shared publications:

  • Alex Christian Nielsen

    Department of Clinical Microbiology, Copenhagen University Hospital, Rigshospitalet , Copenhagen

    2 shared publications
  • Anne-Mette Lebech

    Department of Infectious Diseases, Copenhagen University Hospital, Rigshospitalet , Copenhagen

    2 shared publications
  • Christian Østergaard

    Department of Clinical Microbiology, Copenhagen University Hospital, Hvidovre Hospital , Hvidovre

    2 shared publications
  • Jacob Bodilsen

    Study Group for Infections of the Brain (ESGIB), European Society of Clinical Microbiology and Infectious Diseases, 4051 Basel, Switzerland

    2 shared publications
  • Jens Kjølseth Møller

    Department of Regional Health Research, University of Southern Denmark , Odense

    2 shared publications
  • Kirstine K Søgaard

    Department of Clinical Medicine, Aalborg University , Aalborg

    2 shared publications

Latest Publications

  • Neurological Disorders and Use of Healthcare Services After Bacterial Meningitis in Childhood: A Nationwide, Population-Based Cohort Study

    by Emma E Graham, Malte M Tetens, Jacob Bodilsen, Nanna S Andersen, Ram Dessau, Svend Ellermann-Eriksen, Kristina Franck, Sofie Midgley, Jens Kjølseth Møller, Alex Christian Nielsen, et al.

    In this population-based, nationwide Danish cohort study, bacterial meningitis in childhood was associated with increased neurological morbidity. The risks were highest among young children, who also received more antiepileptic medication. All children had increased frequency of hospital visits. These findings highlight the importance of follow-up after bacterial meningitis in children.


  • Neurological Disorders and Use of Healthcare Services After Enteroviral Meningitis in Childhood: A Nationwide, Population-Based Cohort Study

    by Emma E Graham, Malte M Tetens, Jacob Bodilsen, Nanna S Andersen, Ram Dessau, Svend Ellermann-Eriksen, Kristina Franck, Sofie Midgley, Jens Kjølseth Møller, Alex Christian Nielsen, et al.

    Background: Nervous system infections are associated with long-term risks of neurological disorders and healthcare service utilization, but little data exist on the long-term risks of enteroviral meningitis in childhood. Methods: We performed a population-based, nationwide registry-based matched cohort study (1997-2021). We included 925 children with enteroviral meningitis aged <17 years, a comparison cohort, and a cohort of siblings of all individuals. To illustrate short- and long-term risks of neurological disorders, we calculated 1-year cumulative incidences and age- and sex-adjusted hazard ratios (aHRs) with 95% confidence intervals (95% CIs) during years 1-20 of follow-up. We further calculated the annual proportion of individuals using antiepileptic medication and healthcare services. Results: Young infants (0 to <90 days) and older children (≥90 days to <17 years) had slightly increased short- and long-term risks of neurological disorders after enteroviral meningitis compared to comparison cohort members (1-year cumulative incidence: 1.4% vs 0.6%, and 1.5% vs 0.4%, 1-20-year adjusted hazard ratio: 2.0 [95% CI: 1.2-3.2] and 1.7 [95% CI: 1.0-2.8]). Older children had increased use of antiepileptic medication, as well as the use of health care services both before and after enteroviral meningitis, with a similar trend among their siblings. Conclusions: Enteroviral meningitis in childhood appears to be associated with increased risk of short- and long-term neurological morbidity, though our estimates in older children may be confounded by prior neurological morbidity or increased healthcare-seeking behavior. Our findings suggest a generally good prognosis after enteroviral meningitis, though clinicians should be aware of the risk of neurological disorders in selected patients.


  • Open Access

    Collection of menopause data in studies of women living with HIV: A systematic literature review

    by Emma Eileen Graham, Lina Michala, Anna Hachfeld, Ellen Moseholm, European Aids Clinical Society Women Against Viruses In Europe (Wave)

    Objectives: An increasing number of women living with HIV are transitioning through midlife and menopause. Women living with HIV may experience earlier menopause and a higher symptom burden than women without HIV, but more evidence is needed. Data collection on menopause in women living with HIV is scarce and often not standardized. We sought to assess how menopause data are collected in cohorts and studies of women living with HIV.Methods: This was a literature review conducted within the PubMed database. We included original studies and cohorts assessing menopause and/or menopausal symptoms in women living with HIV. Study characteristics and menopause data collection, including the definition of menopause, symptom assessment tools, and measurement of biomedical parameters, were noted and summarized systematically in data tables.Results: We included 40 articles describing 37 separate studies published between 2000 and 2023; 27 of these were conducted in high‐income countries, the majority in the USA (n = 16). Ten studies were from low‐ and middle‐income countries; four of these were conducted in Brazil. In 20 studies, menopause was defined according to the World Health Organization's definition of over 12 months of amenorrhea. Twelve studies used the Menopause Rating Scale to characterize menopausal symptoms, five studies used other specified symptom assessment tools, and 12 studies used a study‐specific tool.Conclusions: Menopause data collection in women living with HIV is heterogeneous. We propose that standardized tools should be used to enable comparisons between studies and countries, thereby improving the quality of research and clinical treatment. Further research into the validity of menopausal symptom scoring tools is warranted.